Tuesday, 16th April 2024
To guardian.ng
Search

AstraZeneca supports the local community in Kajiado in reforestation

By APO Group
04 May 2021   |   6:00 pm
A collaboration between AstraZeneca (www.AstraZeneca.com) and Global EverGreening Alliance to restore degraded agricultural and forest lands through planting 120 000 trees; the reforestation initiative will be introduced in Kajiado County; the initiative aligns with AstraZeneca’s Global sustainability commitment to environmental protection. The health of our environment is intricately connected to human health. Global Pharmaceutical Company AstraZeneca recognises…

A collaboration between AstraZeneca (www.AstraZeneca.com) and Global EverGreening Alliance to restore degraded agricultural and forest lands through planting 120 000 trees; the reforestation initiative will be introduced in Kajiado County; the initiative aligns with AstraZeneca’s Global sustainability commitment to environmental protection.

The health of our environment is intricately connected to human health.

Global Pharmaceutical Company AstraZeneca recognises the strong connection between a healthy planet and healthy people, and is committed to nurturing environments in which all life can thrive. Trees are a nature-based answer for eliminating CO2 and are fundamental to moderating the impacts of environmental change.

This week the Governor of Kajiado County HE Joseph Ole Lenku; The Principal Secretary at the Ministry of Environment Dr. Chris K. Kiptoo; MP for Kajiado West Hon George Sunkuiya; and the Chairman of the Kenya Forest Service Mr Peter Kinyua, met with Senior Fellow at Global EverGreening Alliance (GEA) – Kenya Chapter, Dr Kenneth Namunje,   AstraZeneca’s Country President for African Cluster (South Africa, Sub Saharan Africa and French Speaking Africa), Barbara Nel,  and AstraZeneca Government Affairs Director SSA, Dr Kennedy Njau  to plant the first of 120 000 trees in Kenya’s Kajiado County. This initiative aligns to AstraZeneca’s global AZ Forest programme, announced at the World Economic Forum in January, which pledged to plant 50 million trees by 2025 in partnership with non-profit global partners One Tree Planted and Global EverGreening Alliance.

The initiative in Kajiado County will harness local knowledge and provide economic opportunities for Small Holder Farmers and rural communities through contracted works such as seed collection, planting and long-term stewardship. The project has engaged approximately 100 Small Holder Farmers to establish nurseries in Kajiado County to nurture the seedings; up to 150 Indigenous and Non-Indigenous business sub-contractors; local seed suppliers and nurseries.

Barbara Nel, AstraZeneca Country President for African Cluster said: “The devastating impacts of drought and wildfires across the globe are a powerful reminder of the impact that the changing climate has on our planet. This is why we are doing our part to help with the reforestation of Kenya.  Our AZ Forest programme in Kenya, in partnership the Global EverGreening Alliance and in collaboration with government is our commitment to support both a healthy environment and improve socioeconomic development and livelihoods for Kenyans in Kajiado County.”

Dr Kenneth Namunje, Senior Fellow at Global EverGreening Alliance (GEA) – Kenya Chapter: “Global EverGreening Alliance Kenya (GEA), an NGO domiciled in Australia, and our partners continue to impact livelihoods through restoration of farmlands, rangelands and forestlands. We take this opportunity to thank AstraZeneca for sponsoring planting of 120,000 Gliricidia Sepium trees in a 3-year program in Kajiado County and we look forward to more collaboration in the future. The Ministry of Agriculture, Ministry of Environment and Forestry and Kenya Forest Service have supported the project.  Zero Two Heros and Green Pasture Network will also collaborate with GEA as community-based implementation partners.”

Distributed by APO Group on behalf of AstraZeneca.

About AstraZeneca:
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit www.AstraZeneca.com and follow the Company on LinkedIn @AstraZeneca.

0 Comments